Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $135.9200 (2.87%) ($135.9200 - $135.9200) on Fri. Oct. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 72 | Latest Price | $135.9200(2.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND advances 1.3% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(57%) IWC(54%) IWN(53%) | Factors Impacting LGND price | LGND will decline at least -1.47% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-5%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | 2.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $131.75(3.17%) | 10 Day Moving Average | $130.57(4.1%) | 20 Day Moving Average | $131.87(3.07%) | To recent high | -4.4% | To recent low | 32.7% | Market Cap | $2.184b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |